Does Rallies show Form 4 insider transactions for RDNT?

Yes. Rallies tracks RDNT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is RDNT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for RDNT. It does not provide personalized investment advice.

RDNT (RadNet, Inc. Common Stock) Stock Analysis - Insider Trades

RadNet, Inc. Common Stock (RDNT) is a publicly traded Healthcare sector company. As of May 19, 2026, RDNT trades at $53.56 with a market cap of $4.12B and a P/E ratio of -300.31. RDNT moved -1.48% today. Year to date, RDNT is -23.65%; over the trailing twelve months it is -11.40%. Its 52-week range spans $45.00 to $93.65. Analyst consensus is strong buy with an average price target of $85.00. Rallies surfaces RDNT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading RDNT stock inside the company?

Recent RDNT insider activity includes Sorensen Alma Gregory sold 9.55K, Sorensen Alma Gregory sold 5.35K, Sorensen Alma Gregory sold 100, Sorensen Alma Gregory sold 14.20K, and Sorensen Alma Gregory sold 800. Rallies tracks insider transaction dates, shares, prices, and estimated values.

RDNT Key Metrics

Key financial metrics for RDNT
Metric	Value
Price	$53.56
Market Cap	$4.12B
P/E Ratio	-300.31
EPS	$-0.18
Dividend Yield	0.00%
52-Week High	$93.65
52-Week Low	$45.00
Volume	133.27K
Avg Volume	0
Revenue (TTM)	$2.14B
Net Income	$22.05M
Gross Margin	0.00%

Recent RDNT Insider Trades

Sorensen Alma Gregory sold 9.55K (~$590.82K) on Mar 19, 2026.
Sorensen Alma Gregory sold 5.35K (~$335.84K) on Mar 19, 2026.
Sorensen Alma Gregory sold 100 (~$6.36K) on Mar 19, 2026.
Sorensen Alma Gregory sold 14.20K (~$882.10K) on Mar 18, 2026.
Sorensen Alma Gregory sold 800 (~$50.18K) on Mar 18, 2026.

Latest RDNT News

Ventripoint’s VMS+ 4.0 Files for NMPA Approval, Showcases at AEPC with Multiple Partnerships — May 19, 2026
RadNet Q1 Revenue Jumps 8.5% to $360.2M; EBITDA Margin Slides 120bp — May 12, 2026
RadNet Sees Revenue Rise but EPS Falls Short in Q1 — May 11, 2026
RadNet’s DeepHealth Debuts AI Platform with 21% Breast Cancer Detection Gain — Mar 4, 2026
RadNet Acquires Gleamer for €230 Million, Projects $30 Million AI Revenue — Mar 3, 2026

RDNT Analyst Consensus

5 analysts cover RDNT: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $85.00.

Common questions about RDNT

Who is trading RDNT stock inside the company?: Recent RDNT insider activity includes Sorensen Alma Gregory sold 9.55K, Sorensen Alma Gregory sold 5.35K, Sorensen Alma Gregory sold 100, Sorensen Alma Gregory sold 14.20K, and Sorensen Alma Gregory sold 800. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for RDNT?: Yes. Rallies tracks RDNT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is RDNT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for RDNT. It does not provide personalized investment advice.